Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034

Description

The pharma and biotech customer relationship management (CRM) software market refers to the specialized segment of CRM systems designed to address the unique needs of pharmaceutical and biotechnology companies. This software supports organizations in managing relationships with healthcare professionals, hospitals, distributors, research institutions, and regulatory bodies.

The pharma and biotech CRM software market consists of sales, by entities (organizations, sole traders, or partnerships), of customer relationship management solutions specifically designed for the pharmaceutical and biotech industries. These solutions enable companies to manage and analyze customer interactions, streamline sales and marketing activities, and maintain compliance with industry regulations.

The global pharma and biotech CRM software market was valued at $2,799.65 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.

Expansion Of Telemedicine And Remote Healthcare

During the historic period, the expansion of telemedicine and remote healthcare supported the growth of the pharma and biotech CRM software market. Telemedicine has created new digital touchpoints between healthcare providers, patients, and pharmaceutical companies, requiring efficient management of communications, prescriptions, and follow-ups. Pharma CRM systems help collect and analyze patient data to enable personalized marketing and enhance patient engagement. They also support seamless multi-channel communication across virtual platforms, phone, and email, crucial for telemedicine's diverse interactions. With travel restrictions limiting in-person meetings, CRM tools facilitate remote sales and marketing through virtual detailing and webinars, maintaining effective stakeholder engagement. For instance, in August 2023, according to the Vivalink, a US-based healthcare technology company, a recent survey found that 81% of clinicians use remote patient monitoring (RPM), up from 20% in 2021, marking a 305% increase. Additionally, 84% of current RPM users plan to expand its use in 2024. Additionally, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, National telehealth use increased by 7.3%, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the expansion of telemedicine and remote healthcare drove the growth of the pharma and biotech CRM software market.

Integrating Electronic Health Records Into Pharma CRM Systems

Major companies operating in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning into their platforms to meet the rising demand for advanced, industry-specific customer engagement tools. AI-powered personalized engagement allows companies to deliver highly targeted and relevant communications to healthcare professionals (HCPs), patients, and other key stakeholders. For example, in October 2023, Salesforce Inc, a US-based cloud software provider, introduced its new Life Sciences Cloud, a secure platform for pharmaceutical (pharma) and medical technology (medtech) organizations. This platform leverages data, automation, and trusted AI to enhance patient engagement, streamline clinical operations, and manage the commercial lifecycle. It supports organizations in delivering personalized stakeholder experiences throughout the drug and device development process. The Life Sciences Cloud integrates data from multiple sources, including electronic health records and clinical trial systems, to provide a unified view of patients and providers. It also offers compliance tools tailored to the regulatory requirements of the healthcare industry.

The global pharma and biotech CRM software market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 94.96% of the total market in 2023.

Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharma and biotech CRM software market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for pharma and biotech CRM software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharma and biotech CRM software market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharma and biotech CRM software market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by deployment, by enterprise size and by industry.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by technology, by deployment, by enterprise size and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for pharma and biotech CRM software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)
2) By Deployment: On-Premise; Cloud-Based
3) By Enterprise Size: Large Enterprises; Small And Medium Enterprises (SMEs)
4) By Industry: Pharmaceuticals; Biotech
Companies Mentioned: Veeva Systems Inc.; IQVIA Holdings Inc.; Salesforce.com Inc.; Oracle Corporation; SAP SE
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharma and biotech CRM software indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1711

1 Executive Summary

1.1 Pharma And Biotech CRM Software - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Pharma And Biotech CRM Software Market Definition And Segmentations
6.4 Market Segmentation By Technology
- 6.4.1 Artificial Intelligence Customer Relationship Management (CRM)
- 6.4.2 Conventional Customer Relationship Management (CRM)
6.5 Market Segmentation By Deployment
- 6.5.1 On-Premises
- 6.5.2 Cloud-Based
6.6 Market Segmentation By Enterprise Size
- 6.6.1 Large Enterprises
- 6.6.2 Small And Medium Enterprises (SMEs)
6.7 Market Segmentation By Industry
- 6.7.1 Pharmaceuticals
- 6.7.2 Biotech

7 Major Market Trends

7.1 Integrating Electronic Health Records Into Pharma CRM Systems
7.2 Strategic Partnerships Driving Innovation In Pharma And Biotech CRM Software
7.3 Voice-Controlled CRM Interfaces Boosting Productivity In Pharma Sales

8 Global Pharma And Biotech CRM Software Growth Analysis And Strategic Analysis Framework

8.1 Global: PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 End Users of B2B Market
- 8.2.1 Pharmaceutical Companies
- 8.2.2 Biotechnology Companies
8.3 Global Market Size and Growth
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Pharma And Biotech CRM Software Total Addressable Market (TAM)

9 Global Pharma And Biotech CRM Software Market Segmentation

9.1 Global Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Pharma And Biotech CRM Software Market, Segmentation By Industry, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Artificial Intelligence Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
9.6 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Conventional Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)

10 Pharma And Biotech CRM Software Market, Regional and Country Analysis

10.1 Global Pharma And Biotech CRM Software Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Pharma And Biotech CRM Software Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Pharma And Biotech CRM Software Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Investments
- 11.33.11 Major Companies
11.34 South Korea Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Pharma And Biotech CRM Software Market: Country Analysis
12.7 UK Market
12.8 UK Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Pharma And Biotech CRM Software Market: Country Analysis
13.7 Russia Market
13.8 Russia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Pharma And Biotech CRM Software Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Region Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 South America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Pharma And Biotech CRM Software Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
16.3 Middle East Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Veeva Systems Inc
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 IQVIA Holdings Inc
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 Salesforce Inc
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Oracle Corporation
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 SAP SE
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Microsoft Corporation
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Zoho Corporation Pvt. Ltd.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Pega Systems Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 HubSpot Inc.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Indegene Private Limited
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Aurea Software Inc.
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Axtria Inc.
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 Pipedrive Inc.
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Syneos Health Inc.
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Close-Up International Limited
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 CRMNEXT Pharmaceutical
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 SugarCRM Inc.
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Creatio (formerly bpm'online)
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 StayinFront Inc.
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Synergistix Inc.
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Valsoft Acquired Exeevo
22.2 Zensar Technologies Acquired BridgeView Life Sciences
22.3 Nomadia Acquired Nomadvantage
22.4 Aktana Acquired Tact.ai

23 Recent Developments In Pharma And Biotech CRM Software Market

23.1 Expansion Of AI-Powered, Region-Specific CRM Solutions In Emerging Markets
23.2 AI-Powered Healthcare Assistant Streamlines Clinical Workflows

24 Opportunities And Strategies

24.1 Global Pharma And Biotech CRM Software Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Pharma And Biotech CRM Software Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Pharma And Biotech CRM Software Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Pharma And Biotech CRM Software Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer